JNJ-77242113
77242113UCO2001
Phase 2 small_molecule completed
Quick answer
JNJ-77242113 for Colitis, Ulcerative is a Phase 2 program (small_molecule) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen Cilag International NV
- Indication
- Colitis, Ulcerative
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed